{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T13:40:13Z","timestamp":1753882813693,"version":"3.41.2"},"reference-count":19,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["SAGE Open Medical Case Reports"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:p> Bullous pemphigoid is an autoimmune blistering disease affecting the dermo-epidermal junction, most commonly seen in older patients. First-line treatment includes systemic, topical corticosteroids and\/or steroid-sparing immunosuppressants. Treatment with these medications may be limited by their safety profile. Dupilumab is a humanized monoclonal antibody targeting interleukin-4 and interleukin-13 cytokines currently indicated for moderate-to-severe atopic dermatitis, severe asthma, chronic rhinosinusitis with nasal polyposis, and moderate-to-severe prurigo nodularis. We report a case of a patient with recalcitrant bullous pemphigoid effectively treated with dupilumab. <\/jats:p>","DOI":"10.1177\/2050313x241274855","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T18:13:07Z","timestamp":1724350387000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Use of dupilumab for recalcitrant bullous pemphigoid: A case report"],"prefix":"10.1177","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-1903-7801","authenticated-orcid":false,"given":"Jillian","family":"Lamb","sequence":"first","affiliation":[{"name":"Division of Clinical Dermatology and Cutaneous Science, Department of Medicine, Dalhousie University, Halifax, NS, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerri","family":"Purdy","sequence":"additional","affiliation":[{"name":"Division of Clinical Dermatology and Cutaneous Science, Department of Medicine, Dalhousie University, Halifax, NS, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0734-1769","authenticated-orcid":false,"given":"Ashley","family":"Sutherland","sequence":"additional","affiliation":[{"name":"Division of Clinical Dermatology and Cutaneous Science, Department of Medicine, Dalhousie University, Halifax, NS, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2024,8,22]]},"reference":[{"issue":"10","key":"bibr1-2050313X241274855","first-page":"61","volume":"57","author":"Pratasava V","year":"2021","journal-title":"Medicina (Lithuania)"},{"issue":"8","key":"bibr2-2050313X241274855","volume":"35","author":"Yang J","year":"2022","journal-title":"Dermatol Ther"},{"issue":"4","key":"bibr3-2050313X241274855","doi-asserted-by":"crossref","DOI":"10.1111\/ijd.16525","volume":"62","author":"Zhang X","year":"2023","journal-title":"Int J Dermatol"},{"key":"bibr4-2050313X241274855","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2021.1907341"},{"issue":"8","key":"bibr5-2050313X241274855","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/ijd.16678","volume":"62","author":"Lin Z","year":"2023","journal-title":"Int J Dermatol"},{"key":"bibr6-2050313X241274855","unstructured":"Health Canada. DUPIXENT\u00ae Canada Product Monograph. February 22, 2021. Available from: https:\/\/pdf.hres.ca\/dpd_pm\/00060069.PDF (accessed May 2024)."},{"issue":"7","key":"bibr7-2050313X241274855","volume":"35","author":"Wang M","year":"2022","journal-title":"Dermatol Ther"},{"issue":"10","key":"bibr8-2050313X241274855","doi-asserted-by":"crossref","first-page":"13488","DOI":"10.1111\/srt.13488","volume":"29","author":"Manzo Margiotta F","year":"2023","journal-title":"Skin Res Technol"},{"issue":"4","key":"bibr9-2050313X241274855","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3390\/biom13040634","volume":"13","author":"Olbrich H","year":"2023","journal-title":"Biomolecules"},{"issue":"10","key":"bibr10-2050313X241274855","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1001\/jamadermatol.2018.2526","volume":"154","author":"Kaye A","year":"2018","journal-title":"JAMA Dermatol"},{"key":"bibr11-2050313X241274855","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-023-00832-1"},{"key":"bibr12-2050313X241274855","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.928621"},{"key":"bibr13-2050313X241274855","doi-asserted-by":"crossref","first-page":"738907","DOI":"10.3389\/fimmu.2021.738907","volume":"12","author":"Zhang Y","year":"2021","journal-title":"Front Immunol"},{"key":"bibr14-2050313X241274855","doi-asserted-by":"crossref","first-page":"109788","DOI":"10.1016\/j.intimp.2023.109788","volume":"116","author":"Liang J","year":"2023","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"bibr15-2050313X241274855","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaad.2020.01.089","volume":"83","author":"Abdat R","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"bibr16-2050313X241274855","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.3390\/jcm11123367","volume":"11","author":"Russo R","year":"2022","journal-title":"J Clin Med"},{"issue":"4","key":"bibr17-2050313X241274855","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/bjd.19631","volume":"184","author":"Sears AV","year":"2021","journal-title":"Br J Dermatol"},{"key":"bibr18-2050313X241274855","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.jid.2018.03.1515","volume":"138","author":"Zhang J","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"2","key":"bibr19-2050313X241274855","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/bjd\/ljad136","volume":"189","author":"Moghadam P","year":"2023","journal-title":"Br J Dermatol"}],"container-title":["SAGE Open Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2050313X241274855","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2050313X241274855","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2050313X241274855","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T01:45:38Z","timestamp":1740879938000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/2050313X241274855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":19,"alternative-id":["10.1177\/2050313X241274855"],"URL":"https:\/\/doi.org\/10.1177\/2050313x241274855","relation":{},"ISSN":["2050-313X","2050-313X"],"issn-type":[{"type":"print","value":"2050-313X"},{"type":"electronic","value":"2050-313X"}],"subject":[],"published":{"date-parts":[[2024,1]]},"article-number":"2050313X241274855"}}